- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Parkinson's disease
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 952KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 58KB)
Apomorphine – November 2020
Apomorphine: Solution for subcutaneous infusion containing apomorphine hydrochloride hemihydrate 50 mg in 10 mL pre-filled syringe; Movapo PFS®
Last updated
5 March 2021